Beyond survival: a cross-sectional analysis of guideline recommendations for cognitive, sexual, and psychological problems in adult cancer survivors
- 1Department of Internal Medicine, Cantonal Hospital of Baden
- 2Division of Cardiology, Cantonal Hospital of Baden
Abstract
As the number of cancer survivors increases globally, greater attention is being directed toward life after cancer. Beneath the surface of remission lies a cluster of silent struggles: cognitive impairments, sexual dysfunction, and psychological distress. The aim was to summarize current recommendations for adult cancer survivors suffering from cognitive impairment, sexual health, and psychological problems. A systematic search of PubMed, the Cochrane Library, and major professional society websites was conducted on 16 January 2025. Guidelines published in English from 1 January 2000 to 31 December 2024 were included if they addressed cognitive, sexual, or psychological issues in adult cancer survivors. Two reviewers independently appraised guideline quality using Appraisal of Guidelines for Research and Evaluation II criteria and extracted recommendations, which were then standardized using the Grading of Recommendations Assessment, Development, and Evaluation framework. Of 523 guidelines screened, 13 guidelines from 7 professional societies met inclusion criteria. Twelve (92.3%) were of moderate quality; one (7.7%) was low quality. Guidelines frequently emphasize addressing long-term survivorship as a different set of challenges, requiring recognition of psychosocial needs. Many guidelines recommended the use of validated tools for assessing cognitive, sexual, and psychological issues. Non-pharmacologic interventions such as education, physical activity, coping strategies, cognitive rehabilitation, and cognitive behavioral therapy were commonly recommended, although evidence levels varied considerably. Multidisciplinary approaches were recommended for survivors with conditions affecting daily life and Quality of Life (QoL). Pharmacologic recommendations were mainly directed toward specific treatment-related complications. PDE5 inhibitors and vaginal estrogens were recommended for survivors experiencing sexual dysfunction, whereas osteoporosis treatment, including bisphosphonates and DEXA monitoring, was recommended for survivors undergoing long-term endocrine therapies or considered at high risk for osteoporosis. Cognitive, sexual, and psychological concerns should be proactively screened and managed in cancer survivors. Non-pharmacologic, patient-centered interventions should be prioritized, with individualized care and shared decision-making.
Related
- Association between cognitive social capital and saliva-related quality of life among head and neck cancer survivors: a cross-sectional study.
- Consideration of person-important outcomes by guideline recommendations for the use of tests and testing strategies: protocol for a meta-epidemiological study
- Recommendations for managing multiple long-term conditions: a systemaftic guideline review and modified Delphi study
- Cognitive-Affective Factors Associated with Psychological Distress in Young Adults: A Cross-Sectional Structural Equation Modelling Study
- Towards global clinical practice guidelines for the management of non-specific low back pain in primary care: a review of current guideline recommendations and how they have changed over the last 30 years
BibTeX
@article{ayoson2026beyond,
title = {{Beyond survival: a cross-sectional analysis of guideline recommendations for cognitive, sexual, and psychological problems in adult cancer survivors}},
author = {Joshua Ayoson and Nadine Schneider and Brian Casanova and Lina Kleijkers and Luca Siragusa and Nina Müller and Rodi Tomar and Sacha I. Rothschild and Katharina Gut-Fischer and Eva Haegler-Laube and Maria M. Wertli},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-61527-1},
url = {https://doi.org/10.1038/s41598-026-61527-1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Beyond survival: a cross-sectional analysis of guideline recommendations for cognitive, sexual, and psychological problems in adult cancer survivors
AU - Joshua Ayoson
AU - Nadine Schneider
AU - Brian Casanova
AU - Lina Kleijkers
AU - Luca Siragusa
AU - Nina Müller
AU - Rodi Tomar
AU - Sacha I. Rothschild
AU - Katharina Gut-Fischer
AU - Eva Haegler-Laube
AU - Maria M. Wertli
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-61527-1
UR - https://doi.org/10.1038/s41598-026-61527-1
AB - As the number of cancer survivors increases globally, greater attention is being directed toward life after cancer. Beneath the surface of remission lies a cluster of silent struggles: cognitive impairments, sexual dysfunction, and psychological distress. The aim was to summarize current recommendations for adult cancer survivors suffering from cognitive impairment, sexual health, and psychological problems. A systematic search of PubMed, the Cochrane Library, and major professional society websites was conducted on 16 January 2025. Guidelines published in English from 1 January 2000 to 31 December 2024 were included if they addressed cognitive, sexual, or psychological issues in adult cancer survivors. Two reviewers independently appraised guideline quality using Appraisal of Guidelines for Research and Evaluation II criteria and extracted recommendations, which were then standardized using the Grading of Recommendations Assessment, Development, and Evaluation framework. Of 523 guidelines screened, 13 guidelines from 7 professional societies met inclusion criteria. Twelve (92.3%) were of moderate quality; one (7.7%) was low quality. Guidelines frequently emphasize addressing long-term survivorship as a different set of challenges, requiring recognition of psychosocial needs. Many guidelines recommended the use of validated tools for assessing cognitive, sexual, and psychological issues. Non-pharmacologic interventions such as education, physical activity, coping strategies, cognitive rehabilitation, and cognitive behavioral therapy were commonly recommended, although evidence levels varied considerably. Multidisciplinary approaches were recommended for survivors with conditions affecting daily life and Quality of Life (QoL). Pharmacologic recommendations were mainly directed toward specific treatment-related complications. PDE5 inhibitors and vaginal estrogens were recommended for survivors experiencing sexual dysfunction, whereas osteoporosis treatment, including bisphosphonates and DEXA monitoring, was recommended for survivors undergoing long-term endocrine therapies or considered at high risk for osteoporosis. Cognitive, sexual, and psychological concerns should be proactively screened and managed in cancer survivors. Non-pharmacologic, patient-centered interventions should be prioritized, with individualized care and shared decision-making.
SN - 2045-2322
ER -